
North Wales Pharma Firm Expands Global Reach with Innovative Product Launches
Prime Highlights: Reacta Healthcare, based in North Wales, is expanding its global reach with two

Prime Highlights: Reacta Healthcare, based in North Wales, is expanding its global reach with two

Prime Highlights: The FDA has approved Innate Pharma’s Phase 3 trial for lacutamab in cutaneous

Prime Highlight: Omada Health will begin prescribing GLP-1s and other obesity medications as part of

Prime Highlights: A dozen drugmakers are developing new weight-loss treatments that prioritize muscle mass preservation

Prime Highlights: Tuberculosis (TB) continues to affect millions globally, with rising concerns over drug-resistant strains.

Prime Highlights: Germany’s Merck KGaA is negotiating to acquire U.S. biotech firm SpringWorks Therapeutics, specializing

Prime Highlights: Eli Lilly plans to release late-stage trial data for Retatrutide in 2025, ahead

Key highlights: Spotlight on emerging Technologies AI-driven Innovation with Dolffia Industry Whitepaper Release NTT DATA

Key Highlights: • $2.5 Million Grant to Expand Testing in Kenya • Significant Improvement in

Key Highlights: High Performance Infrared Imaging AI-powered Data Evaluation and Multi-modal imaging Versatile and customizable